Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer
Clinical trial NCT00749567 · TERMINATED
Trial details
- NCT number
- NCT00749567
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-09-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.